M-A: Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma.

Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-analysis – JAMA Network Open

Commentary on Twitter

This meta-analysis of RCTs shows immune checkpoint inhibitors are associated with demonstrated the superior efficacy and safety of versus standard systemic therapies in patients with unresectable hepatocellular carcinoma. https://t.co/fJdFng69qH

— JAMA Network Open (@JAMANetworkOpen) December 6, 2021